The provider reviews injury history, current presentation, and recovery goals before prescribing any compound
Supplier and the exact listing name, including the fill size, rather than just the compound name Lot identifier, and the date the batch documentation was issued Date received, and the storage conditions and location it went into Date of reconstitution, the diluent used and its lot, and the volume actually added Nominal concentration obtained, stated as nominal rather than as measured Aliquot scheme: how many, what volume, stored where Freeze-thaw count for each aliquot at the point of use Any deviation from plan, including deviations that seemed unimportant at the time Whether the material was research-use-only labeled, which for this listing it is Comparing suppliers on this exact SKU Comparing GHK-CU across suppliers on price alone is comparing two numbers that may not describe the same thing
Safetywise, larazotide has generally shown a favorable profile in trials, with adverse events not significantly different from placebo and mainly involving mild GI symptoms
Identification of cysteine residues involved in disulfide formation in the inactivation of glutathione transferase P-form by hydrogen peroxide
Freezing: do not freeze the reconstituted solution freeze/thaw cycling can degrade the peptides
The amount of water added determines the concentration, measured in milligrams per milliliter (mg/mL)